H.C. Wainwright analyst Douglas Tsao reiterates a Buy rating on Argenx (ARGX) with a $617 price target after the company said it is advancing efgartigimod subcutaneous in all three subtypes of ...
DelveInsight’s 'Myositis Pipeline Insight 2023' report provides comprehensive global coverage of pipeline myositis therapies in various stages of clinical development, major pharmaceutical companies ...
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Idiopathic Inflammatory Myositis - Market Insights, Epidemiology, and Forecast to 2034" report has been added to ResearchAndMarkets.com's offering. This ...
Please provide your email address to receive an email when new articles are posted on . Among patients with myositis, younger individuals with dermatomyositis are more likely to experience pain, while ...
The main inflammatory myopathies within the myositis group include polymyositis, dermatomyositis and inclusion-body myositis (IBM). Although potentially treatable, various practical issues have an ...
Please provide your email address to receive an email when new articles are posted on . Myositis due to immune checkpoint therapy is rare yet severe, with more than half of patients developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results